Includes a series of investments to acquire new equipment and adapt the present ROVI drug product fill-finish facilities and production lines in Spain.
£55 million investment includes a multipurpose ADC manufacturing and aseptic fill/finish facility in Grangemouth and enhanced API manufacturing in Morpeth.
In the first entry of its “Meet the Machine” series, LLS Health highlights a key piece of equipment in its FDA-inspected, commercial manufacturing facility.